Quick Answer
CytoDyn Inc. reported Total Assets of $18.05 million for fiscal year 2025.
CytoDyn Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $18.05M | +62.1% |
| 2024 | $11.14M | -1.4% |
| 2023 | $11.29M | -61.3% |
| 2022 | $29.18M | -77.9% |
| 2021 | $132.08M | +161.5% |
| 2020 | $50.51M | +142.0% |
| 2019 | $20.87M | +326.1% |
| 2018 | $4.90M | -39.2% |
| 2017 | $8.06M | -41.6% |
| 2016 | $13.79M | +194.6% |
| 2015 | $4.68M | -44.5% |
| 2014 | $8.43M | +102.7% |
| 2013 | $4.16M | +288.3% |
| 2012 | $1.07M | -46.3% |
| 2011 | $1.99M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $8.94M | -64.1% | -33.7% |
| August 31, 2025 | $13.48M | -51.9% | -25.3% |
| May 31, 2025 | $18.05M | +62.1% | -14.8% |
| February 28, 2025 | $21.19M | +106.3% | -14.8% |
| November 30, 2024 | $24.88M | +169.2% | -11.2% |
| August 31, 2024 | $28.02M | +125.8% | +151.6% |
| May 31, 2024 | $11.14M | -1.4% | +8.4% |
| February 29, 2024 | $10.27M | -29.9% | +11.1% |
- CytoDyn Inc. showed an increase of +62.1% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, CytoDyn Inc.’s total assets has grown by 804.8% (from $1.99 million to $18.05 million).
- The most recent figure is from CytoDyn Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: